CCR5 and neoplasm: DSF has been reported to inhibit the interaction of FROUNT with CCR2 and CCR5, which decreases tumor associated macrophage (M2) accumulation in the TME, thereby decreasing tumor-promoting properties of tumor associated macrophage [100].